Development, problems and prospects of the treatment of diabetic macular edema
10.3760/cma.j.issn.1005-1015.2013.01.001
- VernacularTitle:糖尿病黄斑水肿的治疗:富有挑战的未尽探索
- Author:
Kun LIU
;
Xun XU
- Publication Type:Journal Article
- Keywords:
Macular edema/drug therapy;
Antibodies,monoclonal/therapeutic use;
Laser coagulation;
Editorial
- From:
Chinese Journal of Ocular Fundus Diseases
2013;(1):1-4
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic macular edema (DME) is a common ocular complication of diabetes patients.It mainly involve macular which is closely related with visual function,thus DME is one of the major reasons causing visual impairment or blindness for diabetes patients.How to reduce the visual damage of DME is always a big challenge in the ophthalmic practice.In the past three decades,there are tremendous developments in DME treatments,from laser photocoagulation,anti-inflammation drugs to anti-vascular endothelial growth factor therapy.However,the mechanism of DME development is not yet completely clear; every existing treatment has its own advantages and weaknesses.Therefore DME treatment still challenges us to explore further to reduce the DME damages.
